Walleye Capital’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
VCM
VPM
Walleye Capital's DXCM Position: Q1 2026 in Review
Walleye Capital reduced its DexCom (DXCM) stake by 100% in Q1 2026, selling an estimated $64.4M and leaving 17 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #4260.
Walleye Capital first reported a position in DXCM in Q1 2019 and has held it in 20 quarters since. The position peaked at $61.4M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Walleye Capital held 17 shares of DexCom worth $1.07K as of Q1 2026.
- Walleye Capital sold 924,645 DexCom shares in Q1 2026, an estimated $64.4M.
- DexCom made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4260 holding.
- Walleye Capital first reported a position in DexCom in Q1 2019 and has held it in 20 quarters since.
- Walleye Capital's DexCom position peaked at $61.4M in Q4 2025.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.